Ajax-Loading

Company Selected - Boston Scientific Corp - Income Statement















Ajax-Loading
Fiscal Year is From January To December - All Figures are in USD, Thousands, Except for the Diluted EPS Figure06/30/202603/31/202612/31/202509/30/2025View Chart

Total Revenue

20,996,00020,615,00020,075,00019,350,000

[-] Cost of Goods Sold (COGS) incl. D&A

6,055,0006,098,0006,221,0006,763,000

Hid COGS excluding D&A

4,642,0004,704,0004,853,0005,412,000

Hid Depreciation & Amortization Expense

1,413,0001,394,0001,368,0001,351,000

Gross Profit

14,940,00014,516,00013,853,00012,587,000

[-] Operating Expenses

10,434,00010,369,0009,882,0009,233,000

Hid Selling General Administrative (SG&A)

7,159,0007,072,0006,888,0006,666,000

Hid Research & Development

2,153,0002,125,0002,052,0001,943,000

Hid Other Operating Expenses

1,122,0001,172,000942,000624,000

Operating Income

4,506,0004,147,0003,971,0003,354,000

[-] Net Interest Income

-334,000-328,000-320,000-232,000

Hid Interest Expense

363,000357,000354,000403,000

Hid Interest Income

189,000.00279,000.00361,000435,000

Hid Total Other Finance Cost

160,000250,000327,000264,000

Total Other Income Expense Net

-645,000-405,000-586,000-84,000

Income Before Tax

3,861,0003,742,0003,385,0003,270,000

Tax Provision

192,000183,000492,000485,000

[-] Net Income Applicable To Common Shares

3,671,0003,561,0002,898,0002,791,000

Hid [-] Net Income

3,667,0003,553,0002,890,0002,788,000

HidHid [-] Net Income Including Non-Controlling Interests

3,669,0003,559,0002,893,0002,785,000

HidHidHid Net Income From Continuing Ops

3,669,0003,559,0002,893,0002,785,000

HidHidHid Discontinued Operations

- - - -

HidHid Minority Interest Expense

-6,000-6,000-6,000-8,000

Hid Preferred Stock And Other Adjustments

-4,000-8,000-8,000-3,000

Diluted EPS

2.462.381.941.87

Diluted Average Shares

1,484,9001,495,0001,495,8001,495,500

EBITDA

5,515,0005,493,0005,107,0005,023,000

EBIT

4,224,0004,099,0003,739,0003,672,000